US President Barack Obama with Indian Prime Minister Manmohan Singh. Official White House Photo by Pete Souza

30 September 2013Americas

India urged to improve its drugs patent policy

India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

CRISPR priority feud ends at USPTO as board reaches decision

30 March 2026 A long-running patent clash over gene editing returns to a fundamental question, as a US court takes another look at the evidence.

Americas

Masimo convinces judge that Apple took secrets—but it’s not enough

19 March 2026 Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge.

Americas

J&J unit targets former employee over alleged mass data theft

17 March 2026 Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios.

More features

UPC appeals court upholds Abbott injunction in glucose monitoring patent dispute

CRISPR priority feud ends at USPTO as board reaches decision

Novartis bets $2bn on biologics as Xolair patents fade

WIPR debuts Global In-House Elite 2026

mRNA litigation: Who’s winning, who’s filing, and what’s next

Dechert boosts litigation bench with partner duo

UK court deals blow to Spanish pharma’s SPC bid for contraceptive

EPO reports record patent filings, but pharma and biotech lag

India urged to improve its drugs patent policy

More on this story

Editor's picks

Editor's picks

More features